PAC-1-temozolomide combination shows promise for anaplastic astrocytoma
A drug that spurs cancer cells to self-destruct has been cleared for use in a clinical trial of patients with anaplastic astrocytoma...
List view / Grid view
News
Report highlights pharma’s key role in Scotland’s economy
Following new Fraser of Allander Institute analysis, the new Director of ABPI Scotland has called upon the Scottish Government to continue to support and prioritise strategic investments in Scotland’s research, development and manufacturing capabilities...
GPS-enabled nanoparticles seek and destroy cancer stem cells
Researchers have developed tiny drug-laden nanoparticles that can seek and destroy cancer stem cells...
Lung function of COPD patients improved with Ultibro Breezhaler
Novartis has announced positive results from the FLASH study examining the safety and efficacy of directly switching COPD patients from Seretide to Ultibro Breezhaler...
Pembrolizumab shows hope for cancerous gestational trophoblastic disease
An immunotherapy drug can be used to cure a rare type of cancer arising from pregnancy when existing treatments have failed...
Virus-like particle vaccine protects against RSV vaccine-enhanced respiratory disease
Researchers have discovered that a virus-like particle vaccine can prime the body's immune response and prevent the severe respiratory diseases...
Antimalarial drugs could support existing cancer treatments
Chloroquine and hydroxychloroquine could make cancer treatments more effective...
Glatiramer acetate found to fight multi-resistant bacteria
Glatiramer acetate, a drug used to treat multiple sclerosis, has been found to have an effect on drug-resistant bacteria...
Budget 2017: Reaction from the UK’s pharmaceutical industry
The Chief Executive of the Association of the British Pharmaceutical Industry (ABPI), Mike Thompson responds to the UK’s Budget announcement...
EC extends license for Zytiga to treat early stage prostate cancer
The EC has granted approval to broaden the existing marketing authorisation for Zytiga to include early stage metastatic prostate cancer...
Lansoprazole a gastric acid suppressant may target TB
A cheap and widely used drug, used to treat conditions such as heartburn, gastritis and ulcers, could work against the bacteria that cause TB...
EMA grants marketing authorisation for Zubsolv for opioid dependence
The EMA has granted a Marketing Authorization for Zubsolv, a novel rapidly-disintegrating treatment option for opioid dependence...
FGF inhibitors may provide a new way to treat high blood pressure
Drugs designed to halt cancer growth may offer a new way to control high blood pressure...
Boehringer Ingelheim makes its best molecules available to the scientific community
Boehringer Ingelheim has announced the launch of a new platform offering free and open access to selected pre-clinical molecules for a non-clinical investigation to scientists worldwide...
EMA to relocate to Amsterdam, the Netherlands
The EMA will relocate to Amsterdam in the Netherlands. The Agency now has just over 16 months to prepare for the move and take up its operations in Amsterdam on 30 March 2019 at the latest...
